Novel PET tracers and their future use in assessment of response to treatment

Acute Lymphocytic Leukemia: impressive results with a bispecific antibody in patients with refractory disease

Treating metastatic melanoma with vemurafenib

Clinical trials for rare tumour types

First line treatment against metastatic breast cancer

Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma

Effects of panitumumab against oesophageal-gastro cancer and carcinomas

Effects of lapatinib and trastuzumab on progression free survival

ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma

President's overview of ASCO 2012

Drug shortage impact on cancer care and efforts to resolve the issue

New BRAF inhibitor dabrafenib delays disease progression in advanced melanoma